The Meunier laboratory at the Queensland Brain Institute had a productive year in 2013. They were awarded two grants to fund their research into neuronal communication and survival. In 2013, the laboratory published eight papers investigating topics like the role of myosin VI in neuroexocytosis and the regulation of neuroexocytosis by Munc18-1. They also demonstrated that inhibition of PIKfyve activity leads to neuronal cell death by disrupting autophagy, implicating this pathway in neurodegenerative diseases. The laboratory continued to study vesicular trafficking and collaborated with other researchers on projects involving neurotoxin transport in neurons and dynamin inhibitors.
The Evolution of In Situ Genetic Technologyasclepiuspdfs
In situ genetic technology was historically developed and mainly focused on detection purpose, allowing specific nucleic acid sequences to be visualized in morphologically preserved tissue sections. With the synergy of genetics and immunohistochemistry, in situ detection can correlate microscopic topological information with gene activity at the transcriptional or post-transcriptional levels in specific tissues. Furthermore, its resolution allows spatial distribution of nucleic acid products to be revealed in a heterogeneous cell population. The newest member to the franchise of in situ genetic technology is a direct-on-specimen enrichment methodology specifically for cell-free DNA liquid biopsy. Contrary to in situ detection, this in-well in situ innovation tackles the very first sample preparation step to reduce material loss, thereby improving overall sensitivity. Genomic nucleic acids purified from specimens have been proven to be time consuming and suffered from damages and losses; the evolution of in situ genetic technology offers a powerful tool for precision functional genomics, enabling cross-check between in vitro and in vivo findings. It further opens the door to ultimate genetic engineering in situ.
The Evolution of In Situ Genetic Technologyasclepiuspdfs
In situ genetic technology was historically developed and mainly focused on detection purpose, allowing specific nucleic acid sequences to be visualized in morphologically preserved tissue sections. With the synergy of genetics and immunohistochemistry, in situ detection can correlate microscopic topological information with gene activity at the transcriptional or post-transcriptional levels in specific tissues. Furthermore, its resolution allows spatial distribution of nucleic acid products to be revealed in a heterogeneous cell population. The newest member to the franchise of in situ genetic technology is a direct-on-specimen enrichment methodology specifically for cell-free DNA liquid biopsy. Contrary to in situ detection, this in-well in situ innovation tackles the very first sample preparation step to reduce material loss, thereby improving overall sensitivity. Genomic nucleic acids purified from specimens have been proven to be time consuming and suffered from damages and losses; the evolution of in situ genetic technology offers a powerful tool for precision functional genomics, enabling cross-check between in vitro and in vivo findings. It further opens the door to ultimate genetic engineering in situ.
Extracellular molecules, such as nucleotides, lipids, short peptides or proteins, are released by cells and bind to receptors on the other cells, which are important mediators in cell-to-cell communications in multicellular organisms. In addition to single molecules, eukaryotic cells can also release membrane vesicles into extracellular environment, such as microvesicles, apoptotic blebs and exosomes.
Methods, Challenges and Future Directions of Radiogenomics-Crimson PublishersCrimsonpublishersCancer
Tissue response to the radiation is a complex pathophysiological process and is an inherited polygenic trait. Aim of the Radiogenomics studies is to discover related genetic variants that confer tumor or nontumor tissue radio sensitivity as the target of radio-sensitizing and/or radio-protective agents and to identify specific genetic markers for prognosis or risk prediction. The methods for radiogenomics studies include candidate gene approaches, genome-wide association studies, Next-Generation Sequencing (NGS), epigenetic study, and other methods. The future direction of radiogenomics should be the development of the polygenic risk scores that are incorporated into end point-specific clinical models/nomograms.
Use of Simulation- based Training for Cancer Education among Nigerian Cliniciansasclepiuspdfs
Background: Among the many limitations of cancer control in Nigeria are lower awareness/competence and poorer training of health-care professionals (HCP). These manifest as deficiencies in advocacy, screening/diagnostic practices, and patient management. Medical simulation (MS) using models is an effective approach for sustainably improving the competence of HCP, especially regarding clinical breast examination (CBE), pelvic examination (PE), and digital rectal examination (DRE). The study evaluates the effect of MS during a Nigerian training course focusing on CBE, PE, and DRE. It answers the question: What is the immediate outcome of MS-based training, as well as the perspectives of HCP on the use of MS for cancer education? Methods: Participants included a convenience sample of Nigerian physicians and nurses who attended the American Society of Clinical Oncology-sponsored Multidisciplinary Cancer Management Course. The intervention was MS using high-fidelity models. The models demonstrated normal anatomic and common pathologic features of the breast, cervical, and prostate. Participants cycled through MS stations (i.e., CBE, PE, and DRE). Pre- and post-training surveys with comments evaluating self-reported comfort levels were the basis for comparison. Data analysis included descriptive statistics, Wilcoxon signed-rank test, Chi-square, and thematic analysis. Results: A total of 51 participants completed course evaluation forms (physicians - 35 and nurses - 16), with an average number of years in practice as 8 (±5.2) years. Pre-training survey showed non-significant differences in practices patterns; 71% (22/35) of physicians rarely performed PE (P=0.92), and 93% (14/16) of nurses rarely performed DRE (P=0.07). According to some participants, “the use of simulation is quite commendable as it gives room for improvement before using a human; it is the best method of learning I have ever enjoyed.” Conclusion: MS-based training significantly improved the comfort levels of participants regarding CBE and PE, as well as their likelihood to perform CBE, PE, and DRE. Participants recommend widespread use of MS for continuing medical education and undergraduate training.
Regular cancer treatment focuses on killing the cancer cells through large doses of medicine, but it also kills other cells in the body and causes significant side effects and potential long-term effects. UCalgary researcher David Cramb – who looks at using nanoparticles to deliver the drugs solely to the tumor in much smaller, more effective quantities shares the potential breakthroughs that can be made possible through nanomedicine both in the treatment and diagnosis of cancer. Watch the full webinar recording: http://www.ucalgary.ca/explore/nanomedicine-new-way-detect-and-treat-cancer
Scientia Professor Katharina Gaus - EMBL Australia Node in Single Molecule Science, ARC Centre of Excellence in Advanced Molecular Imaging, University of New South Wales. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Extracellular molecules, such as nucleotides, lipids, short peptides or proteins, are released by cells and bind to receptors on the other cells, which are important mediators in cell-to-cell communications in multicellular organisms. In addition to single molecules, eukaryotic cells can also release membrane vesicles into extracellular environment, such as microvesicles, apoptotic blebs and exosomes.
Methods, Challenges and Future Directions of Radiogenomics-Crimson PublishersCrimsonpublishersCancer
Tissue response to the radiation is a complex pathophysiological process and is an inherited polygenic trait. Aim of the Radiogenomics studies is to discover related genetic variants that confer tumor or nontumor tissue radio sensitivity as the target of radio-sensitizing and/or radio-protective agents and to identify specific genetic markers for prognosis or risk prediction. The methods for radiogenomics studies include candidate gene approaches, genome-wide association studies, Next-Generation Sequencing (NGS), epigenetic study, and other methods. The future direction of radiogenomics should be the development of the polygenic risk scores that are incorporated into end point-specific clinical models/nomograms.
Use of Simulation- based Training for Cancer Education among Nigerian Cliniciansasclepiuspdfs
Background: Among the many limitations of cancer control in Nigeria are lower awareness/competence and poorer training of health-care professionals (HCP). These manifest as deficiencies in advocacy, screening/diagnostic practices, and patient management. Medical simulation (MS) using models is an effective approach for sustainably improving the competence of HCP, especially regarding clinical breast examination (CBE), pelvic examination (PE), and digital rectal examination (DRE). The study evaluates the effect of MS during a Nigerian training course focusing on CBE, PE, and DRE. It answers the question: What is the immediate outcome of MS-based training, as well as the perspectives of HCP on the use of MS for cancer education? Methods: Participants included a convenience sample of Nigerian physicians and nurses who attended the American Society of Clinical Oncology-sponsored Multidisciplinary Cancer Management Course. The intervention was MS using high-fidelity models. The models demonstrated normal anatomic and common pathologic features of the breast, cervical, and prostate. Participants cycled through MS stations (i.e., CBE, PE, and DRE). Pre- and post-training surveys with comments evaluating self-reported comfort levels were the basis for comparison. Data analysis included descriptive statistics, Wilcoxon signed-rank test, Chi-square, and thematic analysis. Results: A total of 51 participants completed course evaluation forms (physicians - 35 and nurses - 16), with an average number of years in practice as 8 (±5.2) years. Pre-training survey showed non-significant differences in practices patterns; 71% (22/35) of physicians rarely performed PE (P=0.92), and 93% (14/16) of nurses rarely performed DRE (P=0.07). According to some participants, “the use of simulation is quite commendable as it gives room for improvement before using a human; it is the best method of learning I have ever enjoyed.” Conclusion: MS-based training significantly improved the comfort levels of participants regarding CBE and PE, as well as their likelihood to perform CBE, PE, and DRE. Participants recommend widespread use of MS for continuing medical education and undergraduate training.
Regular cancer treatment focuses on killing the cancer cells through large doses of medicine, but it also kills other cells in the body and causes significant side effects and potential long-term effects. UCalgary researcher David Cramb – who looks at using nanoparticles to deliver the drugs solely to the tumor in much smaller, more effective quantities shares the potential breakthroughs that can be made possible through nanomedicine both in the treatment and diagnosis of cancer. Watch the full webinar recording: http://www.ucalgary.ca/explore/nanomedicine-new-way-detect-and-treat-cancer
Scientia Professor Katharina Gaus - EMBL Australia Node in Single Molecule Science, ARC Centre of Excellence in Advanced Molecular Imaging, University of New South Wales. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Pro...DrAlokSharma
Autism spectrum disorders (ASD) are a group of heterogeneous neurodevelopmental disorders characterized by
deficits in verbal and nonverbal communication, social
interaction, and presence of stereotypical repetitive behavior.
Nanotechnology for cancer therapy recent developmentsroshan telrandhe
This paper is an overview of advances and prospects in applications of nanotechnology for cancer treatment. Nanotechnology is an use for prevention, diagnosis, and treatment. nanotechnology offers a promise for the targeted delivery of drugs, genes and protein to tumer tissue and therefore alleviating the toxicity of anticancer agent in healthy tissues. Cancer is one of the leading causes of death worldwide. Nanotechnology is one of the most rapidly growing fields in the 21st centuryThese mainly include arrays of nanocantilevers, nanotubes and nanowires for multiplexing detection, multifunctional injectable nanovectors for therapeutics and diagnostics. This article review current nanotechnology platforms for anticancer drug delivery, including polymeric nanoparticles, liposomes, dendrimers, nanoshells, nuclear acid base nanoparticle [DNA, RNA interference (RNAi), and antisense oligonucleotide (ASO) ] The review increases awarnes of advantages in cancer therapy
Novocus Legal LLP Nanomaterial news update 25-31 march 2018Ruchica Kumar
Purpose of this document is to provide readers with a glimpse of recent developments in technical sector of nanomaterials. We have compiled this document from reported facts and our sources are also given herein.
We firmly believe that this would just be the beginning and there would be many more applications possible of described technique. We are only reporting recent developments, but you might be able to find a new application of the material described herein.
The field of neuroscience is undergoing significant change. The two main cell families that make up the brain, neurons and glial cells, each concealed a hybrid brain cell that fell somewhere in the middle.
A General Overview of Nano Medicine-Efficacy in Therapeutic Science and Curre...Berklin
Nanotechnology’s introduction has dramatically improved a number of scientific fields, one of which is medicinal research. Nanomedicine is aimed to offer healthcare medications and chemicals a new dimension. The small size of nanoparticles, permits them to circulate in the body without interrupting oxygenation and escape filtration by both the renal and gastrointestinal networks. These are the few properties that distinguish them apart from traditional therapeutic procedures. The increased permeability and durability effect result in successful penetration inside the tumor tissues, providing cancer treatment a new lease on life. Efficient transportation pathways, on the other hand, produce genotoxicity and mutagenicity by interacting with genes that are essential for smooth functioning. As the specific interactions of nanomedicines with biological systems are still unknown, comprehending nanomedicines' toxicological effects is tough. The lack of regulatory direction in this field remains a research gap that we would want to examine in this study.
A General Overview of Nano Medicine-Efficacy in Therapeutic Science and Curre...ceijjournals
Nanotechnology’s introduction has dramatically improved a number of scientific fields, one of which is
medicinal research. Nanomedicine is aimed to offer healthcare medications and chemicals a new
dimension. The small size of nanoparticles, permits them to circulate in the body without interrupting
oxygenation and escape filtration by both the renal and gastrointestinal networks. These are the few
properties that distinguish them apart from traditional therapeutic procedures. The increased permeability
and durability effect result in successful penetration inside the tumor tissues, providing cancer treatment a
new lease on life. Efficient transportation pathways, on the other hand, produce genotoxicity and
mutagenicity by interacting with genes that are essential for smooth functioning. As the specific
interactions of nanomedicines with biological systems are still unknown, comprehending nanomedicines'
toxicological effects is tough. The lack of regulatory direction in this field remains a research gap that we
would want to examine in this study.
HMRI Searcher Newsletter Autumn 2014.
The latest health and medical research news from the Hunter Medical Research Institute (HMRI).
Featured research includes ovarian cancer, stroke, organ failure, smoking cessation, melanoma, leukaemia and breast cancer, as well as the latest fundraising and event updates.
Biology, genetics, nanotechnology, neuroscience, materials science, biotech, ...Brian Russell
Over the past two years I've done a lot of interesting research which I've decided to aggregate. My research pertains to the following: Biology, Genetics, Nanotechnology, Neuroscience, Materials Science, Biotechnology, Chemical Engineering, All Things 3-D, Super Computing, Quantum Physics, Energy, Design, & Sustainability.
Human organoid are miniature sized, self-organized structures, that are derived from stem cells or tissues in culture. The progress, potential, limitations and challenges are discussed.
3. Mobile autophagosomes in neuronal
networks.
2013 was a year of many achievements for the
Meunier laboratory, including the award of two
grants, namely a National Health and Medical
Research Council Project grant and an Australian
Research Council LIEF grant to equip QBI with
some of the most exciting new technologies
in super resolution microscopy. In 2013, the
laboratory published eight peer-reviewed
publications and was asked to join the Clem Jones
Centre for Ageing Dementia Research (CJCADR).
The team has continued to pursue its work into
the mechanism of neuroexocytosis. This year
the group published the discovery that Myosin
VI plays a key role in capturing secretory vesicles
on the cortical actin network in an activity-de-
pendent manner (Journal of Cell Biology). They
also revealed that Munc18-1 not only controls the
delivery of Syntaxin-1 to the plasma membrane
but also regulates neuroexocytosis itself through
a key role of its domain 3a (Journal of Cell
Science). Additionally, they showed a novel type
of plasticity allows filopodial extensions to create
new release sites in response to secretagogue
stimulation (Journal of Neuroscience).
In terms of vesicular trafficking, the Meunier
laboratory demonstrated that pharmacological
inhibition of PIKfyve activity leads to an apopto-
sis-independent neuronal cell death, implicating
a dysregulation of autophagy. This pathway is
thought to be involved in a number of neuro-
degenerative diseases, including Charcot-Marie
Tooth and motor neuron disease (PLOS ONE).
The group investigated the traffic of synthetic
self-assembling clostridial chimera neurotoxin in
neurons in collaboration with Professor Bazbek
Davletov (MRC Laboratory of Molecular Biology,
UK). They also reviewed the literature on the
potential of blocking endocytic pathways to
counteract pathogens internalisation (Trends
in Cell Biology) and pursued their collabora-
tion with Professor Phillip Robinson (University
of Sydney) and Professor Adam McCluskey
(University of Newcastle) on a range of highly
effective dynamin inhibitors (Traffic).
The mechanism underpinning neuronal communication and survival
2013 Laboratory Members L-R: Frederic Meunier, Rachel Gormal, Callista Harper, Ravikiran Kasula, David Kvaskov, Regine Low, Nancy Malintan, Sally Martin, Nika Mohannak, Vinod Narayana,
Tam Hong Nguyen, Shona Osborne, Andreas Papadopulos, Vanesa Tomatis, Tong (Iris) Wang. Not pictured: Adekunle Bademosi, Shi Min (Priscilla) Goh. Background: Super-resolution
microscopy enables the visualisation and tracking of lipid molecules on the plasma membrane. The movements of cholera toxin, which binds to the ganglioside GM1, are shown. Studying
the diffusion of these individual molecules provides information on how the plasma membrane responds to stimuli. Image: Callista Harper.
QBI ANNUAL REPORT40
Laboratory Head Associate Professor Frederic Meunier*